| Financial Year |
March 31 2023 |
| Monetary Funds |
70,392,578.10 |
| Held-for-trading Financial Assets |
124,706,440.82 |
| Notes Receivable |
863,910.38 |
| Accounts Receivable |
431,256,980.28 |
| Advances to Suppliers |
130,954,111.86 |
| Other Receivables |
39,110,816.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
741,185,834.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
73,123,511.51 |
| Total Current Assets |
1,614,244,772.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
205,713,237.88 |
| Investment Properties |
-- |
| Fixed Assetes |
75,069,308.92 |
| Under-construction Projects |
156,867,902.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
179,868,901.27 |
| R&D expenses |
97,929,151.80 |
| Goodwill |
54,014,463.28 |
| Long-Term Deferred and Prepaid Expenses |
5,207,022.35 |
| Deferred Income Tax Assets |
208,716,890.52 |
| Other Non-Current Assets |
21,413,351.27 |
| Sub-Total of Non-Current Assets |
1,056,080,428.35 |
| Total Assets |
2,670,325,201.00 |
| Short-Term Loans |
157,965,425.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
223,362,305.71 |
| Accounts Payable |
304,689,267.56 |
| Accounts Received In Advance |
96,363.00 |
| Employee Compensation Payable |
22,174,968.53 |
| Taxes Payable |
94,609,665.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,147,874.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,035,558.67 |
| Other Current Liabilities |
13,692,550.29 |
| Sub-Total of Current Liabilities |
1,101,919,269.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
390,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
25,322,493.80 |
| Total Liabilities |
1,127,241,763.07 |
| Paid-In Capital(Or Share Stock) |
1,449,824,087.00 |
| Capital Surplus |
315,877,885.28 |
| Surplus Reserve |
58,426,462.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-268,187,448.57 |
| Minority Stockholder's Interest |
-9,468,234.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,552,551,672.18 |
| Owner's Equity（Stockholder's Equity） |
1,543,083,437.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,670,325,201.00 |
